Cargando…

Hepatic Inflammatory Pseudotumor—Focusing on Its Heterogeneity

Hepatic inflammatory pseudotumors (IPTs) are defined as benign, non-malignant, non-metastasizing tumors characterized by the presence of myofibroblastic spindle cells, hetorogenous populations of inflammatory cells, particularly plasma cells, lymphocytes and macrophages, as well as locations of fibr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Soo Ryang, Kim, Soo Ki, Koma, Yu-ichiro, Sasaki, Motoko, Asai, Akira, Nishikawa, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486865/
https://www.ncbi.nlm.nih.gov/pubmed/37685395
http://dx.doi.org/10.3390/diagnostics13172857
_version_ 1785103097815629824
author Kim, Soo Ryang
Kim, Soo Ki
Koma, Yu-ichiro
Sasaki, Motoko
Asai, Akira
Nishikawa, Hiroki
author_facet Kim, Soo Ryang
Kim, Soo Ki
Koma, Yu-ichiro
Sasaki, Motoko
Asai, Akira
Nishikawa, Hiroki
author_sort Kim, Soo Ryang
collection PubMed
description Hepatic inflammatory pseudotumors (IPTs) are defined as benign, non-malignant, non-metastasizing tumors characterized by the presence of myofibroblastic spindle cells, hetorogenous populations of inflammatory cells, particularly plasma cells, lymphocytes and macrophages, as well as locations of fibrosis and necrosis without cellular anaplasia or atypical mitoses. Despite subsequent reports in the references, hepatic IPT remains difficult to diagnose; while posing major issues specifically for its differential diagnosis compared with that of other various benign diseases and malignant hepatic tumors. Histopathological findings are always a requisite for confirming the diagnosis, particularly given that the pathogenesis of IPT remains ambiguous to date. Hepatic IPT is a heterogeneous entity in terms of its clinical features, pathological findings, and pathogenesis. Once the diagnosis is confirmed, however, needless surgery such as wedge resection and lobectomy should be avoided. Here, we discuss the heterogeneity of hepatic IPT, its clinical features, pathological findings, and pathogenesis, and describe its differential diagnosis.
format Online
Article
Text
id pubmed-10486865
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104868652023-09-09 Hepatic Inflammatory Pseudotumor—Focusing on Its Heterogeneity Kim, Soo Ryang Kim, Soo Ki Koma, Yu-ichiro Sasaki, Motoko Asai, Akira Nishikawa, Hiroki Diagnostics (Basel) Review Hepatic inflammatory pseudotumors (IPTs) are defined as benign, non-malignant, non-metastasizing tumors characterized by the presence of myofibroblastic spindle cells, hetorogenous populations of inflammatory cells, particularly plasma cells, lymphocytes and macrophages, as well as locations of fibrosis and necrosis without cellular anaplasia or atypical mitoses. Despite subsequent reports in the references, hepatic IPT remains difficult to diagnose; while posing major issues specifically for its differential diagnosis compared with that of other various benign diseases and malignant hepatic tumors. Histopathological findings are always a requisite for confirming the diagnosis, particularly given that the pathogenesis of IPT remains ambiguous to date. Hepatic IPT is a heterogeneous entity in terms of its clinical features, pathological findings, and pathogenesis. Once the diagnosis is confirmed, however, needless surgery such as wedge resection and lobectomy should be avoided. Here, we discuss the heterogeneity of hepatic IPT, its clinical features, pathological findings, and pathogenesis, and describe its differential diagnosis. MDPI 2023-09-04 /pmc/articles/PMC10486865/ /pubmed/37685395 http://dx.doi.org/10.3390/diagnostics13172857 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kim, Soo Ryang
Kim, Soo Ki
Koma, Yu-ichiro
Sasaki, Motoko
Asai, Akira
Nishikawa, Hiroki
Hepatic Inflammatory Pseudotumor—Focusing on Its Heterogeneity
title Hepatic Inflammatory Pseudotumor—Focusing on Its Heterogeneity
title_full Hepatic Inflammatory Pseudotumor—Focusing on Its Heterogeneity
title_fullStr Hepatic Inflammatory Pseudotumor—Focusing on Its Heterogeneity
title_full_unstemmed Hepatic Inflammatory Pseudotumor—Focusing on Its Heterogeneity
title_short Hepatic Inflammatory Pseudotumor—Focusing on Its Heterogeneity
title_sort hepatic inflammatory pseudotumor—focusing on its heterogeneity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486865/
https://www.ncbi.nlm.nih.gov/pubmed/37685395
http://dx.doi.org/10.3390/diagnostics13172857
work_keys_str_mv AT kimsooryang hepaticinflammatorypseudotumorfocusingonitsheterogeneity
AT kimsooki hepaticinflammatorypseudotumorfocusingonitsheterogeneity
AT komayuichiro hepaticinflammatorypseudotumorfocusingonitsheterogeneity
AT sasakimotoko hepaticinflammatorypseudotumorfocusingonitsheterogeneity
AT asaiakira hepaticinflammatorypseudotumorfocusingonitsheterogeneity
AT nishikawahiroki hepaticinflammatorypseudotumorfocusingonitsheterogeneity